Literature DB >> 12573815

Androgen receptor mutations and androgen insensitivity.

Michael J McPhaul1.   

Abstract

The androgen receptor (AR) is a high affinity receptor protein encoded on the human X-chromosome that mediates the actions of androgens during development and in the adult. Defects in this receptor protein result in a wide range of abnormalities of male sexual development. Studies in a number of different laboratories have identified mutations of the AR gene in subjects with androgen resistance syndromes. Defects that interrupt the AR open-reading frame have been traced to a number of distinct types of genetic alterations, have been identified in widely separated segments of the AR gene, and are invariably associated with the phenotype of complete androgen insensitivity. By contrast, mutations that cause single amino acid substitutions within the AR are localized to the DNA- or ligand-binding domains of the receptor protein and have been associated with the full range of androgen resistant phenotypes. The diversity of mutations that have been identified has prompted a consideration of the relationship between AR mutation and phenotype. Analyses of AR abundance and function suggest that the phenotypic abnormalities that result from mutation of the AR reflect the extent to which AR activity is impaired in target tissues. Such decreases in AR function may be the result of the diminished receptor function, decreases in receptor concentration, or a combination of these two effects. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12573815     DOI: 10.1016/s0303-7207(02)00369-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  26 in total

Review 1.  Of mice and rats: key species variations in the sexual differentiation of brain and behavior.

Authors:  P J Bonthuis; K H Cox; B T Searcy; P Kumar; S Tobet; E F Rissman
Journal:  Front Neuroendocrinol       Date:  2010-05-10       Impact factor: 8.606

Review 2.  "Getting from here to there"--mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer.

Authors:  Nima Sharifi; Michael J McPhaul; Richard J Auchus
Journal:  J Investig Med       Date:  2010-12       Impact factor: 2.895

Review 3.  A genetic approach to dissect sexually dimorphic behaviors.

Authors:  Scott A Juntti; Jennifer K Coats; Nirao M Shah
Journal:  Horm Behav       Date:  2008-01-05       Impact factor: 3.587

4.  Complete androgen insensitivity syndrome.

Authors:  Hemant Deshpande; Shilpa Chaudhari; Shivani Sharma
Journal:  J Obstet Gynaecol India       Date:  2013-03-12

Review 5.  Transcriptional switches: chemical approaches to gene regulation.

Authors:  Lori W Lee; Anna K Mapp
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

Review 6.  Androgenetic alopecia: a review.

Authors:  Francesca Lolli; Francesco Pallotti; Alfredo Rossi; Maria C Fortuna; Gemma Caro; Andrea Lenzi; Andrea Sansone; Francesco Lombardo
Journal:  Endocrine       Date:  2017-03-28       Impact factor: 3.633

7.  Expression of humoral autoimmunity is related to androgen receptor CAG repeat length in men with systemic lupus erythematosus.

Authors:  Alex H Tessnow; Nancy J Olsen; William J Kovacs
Journal:  J Clin Immunol       Date:  2011-03-29       Impact factor: 8.317

Review 8.  Mechanisms of androgen receptor activation in castration-resistant prostate cancer.

Authors:  Nima Sharifi
Journal:  Endocrinology       Date:  2013-09-03       Impact factor: 4.736

Review 9.  Targeting the androgen receptor pathway in prostate cancer.

Authors:  Yu Chen; Charles L Sawyers; Howard I Scher
Journal:  Curr Opin Pharmacol       Date:  2008-08-12       Impact factor: 5.547

10.  The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?

Authors:  Véronique Douard; Frédéric Brunet; Bastien Boussau; Isabelle Ahrens-Fath; Virginie Vlaeminck-Guillem; Bernard Haendler; Vincent Laudet; Yann Guiguen
Journal:  BMC Evol Biol       Date:  2008-12-18       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.